Insider · CIK 0001319485

Keith Curtis T

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001319485

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2006-07-12	EPIRUS Biopharmaceuticals, Inc.Incentive Stock Option (right to buy)A Award	Senior VP, Research	AAward	+3,516 sh	—	—	3,516
2006-07-12	EPIRUS Biopharmaceuticals, Inc.Non-Qualified Stock Option (right to buy)A Award	Senior VP, Research	AAward	+15.2K sh	—	—	15,234
2006-07-07	EPIRUS Biopharmaceuticals, Inc.M Exercise/Conversion	Senior VP, Research	MExercise/Conversion	+7,500 sh	$0.87	+$6,520.5	75,357
2006-07-07	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$8.42	−$6,315	74,607
2006-07-07	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−1,500 sh	$8.48	−$12.7K	73,107
2006-07-07	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$8.76	−$6,570	72,357
2006-07-07	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$8.79	−$6,592.5	71,607
2006-07-07	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$8.81	−$6,607.5	70,857
2006-07-07	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$8.84	−$6,630	70,107
2006-07-07	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$8.87	−$6,652.5	69,357
2006-07-07	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$8.89	−$6,667.5	68,607
2006-07-07	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$8.91	−$6,682.5	67,857
2006-07-07	EPIRUS Biopharmaceuticals, Inc.Incentive Stock Option (right to buy)M Exercise/Conversion	Senior VP, Research	MExercise/Conversion	−7,500 sh	—	—	30,714
2006-07-05	EPIRUS Biopharmaceuticals, Inc.M Exercise/Conversion	Senior VP, Research	MExercise/Conversion	+7,500 sh	$0.87	+$6,520.5	75,357
2006-07-05	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$8.57	−$6,427.5	74,607
2006-07-05	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−1,500 sh	$9.05	−$13.6K	73,107
2006-07-05	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$9.06	−$6,795	72,357
2006-07-05	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$9.09	−$6,817.5	71,607
2006-07-05	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$9.10	−$6,825	70,857
2006-07-05	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$9.15	−$6,862.5	70,107
2006-07-05	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$8.99	−$6,742.5	69,357
2006-07-05	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$9.06	−$6,795	68,607
2006-07-05	EPIRUS Biopharmaceuticals, Inc.S Sale	Senior VP, Research	SSale	−750 sh	$9.11	−$6,832.5	67,857
2006-07-05	EPIRUS Biopharmaceuticals, Inc.Incentive Stock Option (right to buy)M Exercise/Conversion	Senior VP, Research	MExercise/Conversion	−7,500 sh	—	—	38,214

Recent filings

Accepted (ET)
Jul 144
Keith Curtis T0001135906-06-000029
SEC(opens sec.gov)
Jul 114
COMBINATORX, INC0001135906-06-000015
SEC(opens sec.gov)
Jul 74
COMBINATORX, INC0001135906-06-000009
SEC(opens sec.gov)

Companies

Address

C/O TRANSLATIONAL DEVELOPMENT ACQ CORP. 52 E. 83RD STREET

NEW YORK, NY, 10028